Search For "cipla stock market pharma news business news"
Cipla secures USFDA approval for pancreatic disease injection, shares surg
Updated : 2 years ago IST
Mumbai-headquartered pharma major, Cipla's US arm has secured final approval from the United States Food and Drug Administration (USFDA) for its Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, and 60 mg/0.2 mL.
Read More